Tissue Regeneration Systems
Kirkland
About Tissue Regeneration Systems
Tissue Regeneration Systems (TRS) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin. Our technology has been evaluated in several large animal studies with very promising long term results. We have conceptualized initial product offerings, completed all required bench and animal testing, and filed our first regulatory submissions to the FDA. Approval of these submissions will allow TRS to commercialize products in the United States and we expect to begin generating meaningful revenues in the next two to three years.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.3M
- Last round: Series Unknown (May 2015)
- Website: tissuesys.com
- Phone: 734-395-6367
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tissue-regeneration-systems-2956307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.